DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Smith MR, Saad F, Hussain M. et al.
ARASENS: a phase 3 trial of darolutamide in combination with docetaxel for men with metastatic hormone-sensitive prostate cancer (mHSPC).
JCO 2018;
36 (Suppl. 06) TPS383-TPS383
Access:
We do not assume any responsibility for the contents of the web pages of other providers.